Related content

Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature

By Lavecchia Antonio   Di Giovanni Carmen   Cerchia Carmen  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 383-400

Informa Healthcare

Access to resources Recommend Favorite

Signal transducer and activator of transcription 3 inhibitors: a patent review

By Page Brent DG   Ball Daniel P   Gunning Patrick T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 65-83

Informa Healthcare

Access to resources Recommend Favorite

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors

By Mankan Arun K   Greten Florian R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1263-1275

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-6-induced Activation of Signal Transducer and Activator of Transcription-3 in Ruptured Rotator Cuff Tendon

By Nakama K   Gotoh M   Yamada T   Mitsui Y   Yasukawa H   Imaizumi T   Higuchi FK   Nagata K  

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 624-631

Field House Publishing

Access to resources Recommend Favorite

Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 4, 2005-01 ,pp. : 449-463

Bentham Science Publishers

Access to resources Recommend Favorite